SecBot

SecBot
Nasdaq· Surgical & Medical Instruments & Apparatus· Inc. L3· CIK 0001837493

IINN

QTREX Quantum Ltd.
—
12-mo target$5.00 (+1215.8%)
Healthcare & Medical Devices
Snapshot
The big-picture read on IINN right now — valuation, ownership and activity at a glance.
Press Releases
12
Price chart
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 1, 2026 contract
QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader
A leading quantum computing company tested QTREX's AME interconnect at 20 mK: over 100 dB channel is
May 29, 2026 Press
QTREX Quantum (QTEX) announced a $10M private placement of 6.67M ordinary shares to a new institutional investor, with p
Impact 5/10
May 18, 2026 Press
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its FDA-cleared ART100
Impact 5/10
Analyst ratings buy % +0.0%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
Recent analyst actions
DateFirmActionRatingFirm rating
Jun 2, 2025Litchfield HillsINITIATEBuy 28%
Monthly consensus history
PeriodStr. BuyBuyHoldSellStr. SellBuy %Distribution
May 1, 20262410086%
Apr 1, 20262410086%
Mar 1, 20262410086%
Feb 1, 20262410086%
Jan 1, 20262410086%
Price targets
Where 1 covering analysts think IINN trades over the next 12 months.
$5.00 +1215.8% upside Strong Buy
Current$0.3800 Low$5.00 Median$5.00 High$5.00 1 analysts
$5.00$5.00
Analyst rating None as of Jul 21, 2026
Social media sentiment
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
Recent posts
pennystocks Neutral 7mo ago
Inspira Technologies: A Micro-Cap MedTech Play With Unusual Commercial Momentum (NASDAQ: IINN)
▲ 5 · 💬 3· ⚡ 0.0
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
MIXED5/10
QTREX Quantum (QTEX) announced a $10M private placement of 6.67M ordinary shares to a new institutio
May 29, 2026
BULLISH5/10
Inspira Technologies received a $580,000 commercial purchase order from NYU Langone Hospital for its
May 18, 2026
NEUTRAL5/10
Inspira Technologies issued a shareholder letter outlining a strategic pivot into quantum connectivi
May 11, 2026
NEUTRAL4/10
Inspira Technologies secured a $596,000 purchase order for its AME system from a leading Irish techn
May 1, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Oct 1, 2026
contract
QTREX Interconnect Independently Tested at 20 mK by a Leading Quantum Computing Company; Over 100 dB Channel Isolation, 60 dB Beyond the Market Leader
A leading quantum computing company tested QTREX's AME interconnect at 20 mK: over 100 dB channel isolation, 60 dB beyond the market leader.
Sep 24, 2026
earnings
QTREX Quantum Reports First Half 2026 Financial Results
QTREX Quantum reports record first half 2026 revenue of $1.55 million, up 438%, with a 61% gross margin, all from its AME and Quantum segment.
Aug 31, 2026
announcement
Correction: QTREX Establishes Cryogenic Interconnect Capacity, More Than Four Times the Highest Publicly Disclosed Industry Benchmark
QTREX will unveil a cryogenic interconnect architecture designed to support 17,280 coaxial lines per stage at IEEE Quantum Week 2026 in Toronto.
Aug 31, 2026
announcement
QTREX to Unveil Ultra-High-Density Interconnect Architecture Supporting 17,280 Coaxial Lines per Cryogenic Stage at IEEE Quantum Week 2026
QTREX will unveil a cryogenic interconnect architecture designed to support 17,280 coaxial lines per stage at IEEE Quantum Week 2026 in Toronto.
Jul 31, 2026
announcement
QTREX Proprietary Quantum Interconnect Platform Exceeds Performance Requirements Established by Strategic Partners
QTREX’s proprietary coaxial quantum interconnect platform exceeded partner-defined RF performance requirements across key parameters.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
PeriodEPS Est.RangeGrowth30d RevUp/DnRevenue#
Next Q$0.00$0.00–$0.00———$0.0B—
Next FY$0.00$0.00–$0.00———$0.0B—
Current Q$0.00$0.00–$0.00———$0.0B—
Current FY$0.10$0.10–$0.10122.2%-9.1%1↑ 0↓$0.0B1
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for IINN.
Shares short
813,529
Settlement May 15, 2026
Change vs prior
-10.3%
Semi-monthly cycle
Days to cover
3.1
At avg daily volume
All IINN filing & press-release reports (12)